Technical Analysis for ACHV - Achieve Life Sciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 4.45 | -2.74% | -0.13 |
ACHV closed unchanged on Thursday, April 18, 2024, on 74 percent of normal volume. It was able to find support at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
Earnings due: May 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | -2.74% | |
| 20 DMA Support | Bullish | -2.74% | |
| 50 DMA Support | Bullish | -2.74% | |
| MACD Bullish Centerline Cross | Bullish | -2.74% | |
| MACD Bullish Signal Line Cross | Bullish | -2.74% | |
| Bollinger Band Squeeze | Range Contraction | -2.74% | |
| Doji - Bearish? | Reversal | -2.74% | |
| Outside Day | Range Expansion | -2.74% | |
| Crossed Above 20 DMA | Bullish | -2.74% | |
| Crossed Above 50 DMA | Bullish | -2.74% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 18 minutes ago |
| Down 3% | 18 minutes ago |
| Fell Below 20 DMA | 18 minutes ago |
| Down 2 % | about 1 hour ago |
| Possible Inside Day | about 1 hour ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 10.25 |
| 52 Week Low | 3.03 |
| Average Volume | 105,795 |
| 200-Day Moving Average | 4.60 |
| 50-Day Moving Average | 4.42 |
| 20-Day Moving Average | 4.50 |
| 10-Day Moving Average | 4.43 |
| Average True Range | 0.22 |
| RSI (14) | 55.56 |
| ADX | 13.56 |
| +DI | 16.28 |
| -DI | 14.41 |
| Chandelier Exit (Long, 3 ATRs) | 4.16 |
| Chandelier Exit (Short, 3 ATRs) | 4.67 |
| Upper Bollinger Bands | 4.70 |
| Lower Bollinger Band | 4.29 |
| Percent B (%b) | 0.67 |
| BandWidth | 9.12 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0037 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.96 | ||||
| Resistance 3 (R3) | 4.94 | 4.80 | 4.90 | ||
| Resistance 2 (R2) | 4.80 | 4.70 | 4.81 | 4.87 | |
| Resistance 1 (R1) | 4.68 | 4.64 | 4.61 | 4.70 | 4.85 |
| Pivot Point | 4.54 | 4.54 | 4.50 | 4.55 | 4.54 |
| Support 1 (S1) | 4.42 | 4.44 | 4.35 | 4.44 | 4.29 |
| Support 2 (S2) | 4.28 | 4.38 | 4.29 | 4.27 | |
| Support 3 (S3) | 4.16 | 4.28 | 4.25 | ||
| Support 4 (S4) | 4.18 |
